Price | Negotiable |
MOQ | 1000 |
Delivery Time | 7 Days |
Brand | WWHS |
Place of Origin | CN |
Certification | ISO 13485, CE |
Model Number | PSA |
Packaging Details | Colorful Paper Box |
Payment Terms | L/C, T/T |
Supply Ability | 20000 Kits per Week |
Place of Origin | CN | Keywords | High Stability, High Sensitivity, High Accuracy |
Packaging Details | Colorful Paper Box | Product Name | PSA Rapid Quantitative Test Kit |
Model Number | PSA | Supply Ability | 20000 Kits per Week |
Certification | ISO 13485, CE | Brand Name | WWHS |
Payment Terms | L/C, T/T | Assay | Fluorescence immunoassay |
Type | One Step Assay | Storage | Room Temperature |
Price | Negotiable | Delivery Time | 7 Days |
Formal Name | Prostate Specific Antigen | Minimum Order Quantity | 1000 |
Manufacturer | WWHS BIOTECH INC | Package | 20 Tests |
Application | Human | Sample Buffer | 25 Vials |
【Product name】35. tPSA.pdf
Prostate Specific Antigen (PSA) Rapid Quantitative Test(Fluorescence immunoassay)
WWHS Assay list | ||||||
Tumor Maker | ||||||
cat#. | Product item | Specimen | Reaction Time | Measure Range | Clinical Range | Itended Use |
20 | AFP | Serum/Plasma | 15min. | 2.5-200ng/ml | <20ng/ml | pregnancy cancer |
21 | CEA | Serum/Plasma | 15min. | 1-200ng/ml | <5ng/ml | colon cancer, colorectal cancer,etc. |
22 | NSE | Serum/Plasma | 15min. | 1-400ng/ml | <16ng/ml | non-small cell lung cancer |
23 | FOB | fecal specimens | 10min. | 50-1000ng/ml | <100ng/ml | Abnormal recessive gastrointestinal bleeding |
24 | PG II | Serum/Plasma | 15min. | 1-100ug/L | PGI/PGII>3.0 | gastric abnormalities |
25 | PG I | Serum/Plasma | 15min. | 2.5-200ug/L | >70ng/ml | gastric abnormalities |
26 | TPSA | Serum/Plasma | 15min. | 0.5-40ng/ml | <4ng/ml | prostate cancer |
27 | FPSA | Serum/Plasma | 15min. | 0.1-10ng/ml | <1ng/ml | prostate cancer |
28 | CA12-5 | Serum/Plasma | 15min. | 20-500U/ml | <35U/ml | ovarian cancer |
29 | CA15-3 | Serum/Plasma | 15min. | 10-400U/ml | < 25 U/mL | breast cancer |
30 | HE4 | Serum/Plasma | 15min. | 50-2000pmol/L | <140 pmol/L | ovarian cancer |
31 | CA19-9 | Serum/Plasma | 15min. | 10-400U/ml | < 27 U/mL | pancreatic cancer |
32 | β-HCG | Serum/Plasma | 15min. | 5-400mIU/ml | <10 mIU/mL | Early pregrancy, ectopic HCG cancer,incomplete abortion |
33 | CK19(Cyfra21-1) | Serum/Plasma | 15min. | 0.5-50ng/ml | <2.5ng/ml | non-small cell lung cancer |